Shefferman Jesse (CIK 1799167) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy TARA (215,687 shares), Sell TARA (215,687 shares), Sell TARA (14,000 shares), Sell TARA (7,000 shares), Sell TARA (4,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Protara Therapeutics, Inc. (TARA) | CEO and President | Buy | 215,687 | $411,962 |
| 2026-07-01 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 215,687 | $882,160 |
| 2026-07-01 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 14,000 | $0 |
| 2026-07-01 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 7,000 | $0 |
| 2026-07-01 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 4,000 | $0 |
| 2026-07-01 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 5,000 | $0 |
| 2026-01-27 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 8,732 | $58,242 |
| 2026-01-22 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 16,322 | $91,403 |
| 2026-01-21 | Protara Therapeutics, Inc. (TARA) | CEO and President | Buy | 87,000 | $0 |
| 2025-07-07 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 300,000 | $0 |
| 2025-06-30 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 1,700 | $0 |
| 2025-06-30 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 3,400 | $0 |
| 2025-06-30 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 10,200 | $0 |
| 2025-06-30 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 3,367 | $0 |
| 2025-01-28 | Protara Therapeutics, Inc. (TARA) | CEO and President | Buy | 65,000 | $0 |
| 2025-01-23 | Protara Therapeutics, Inc. (TARA) | CEO and President | Sell | 15,469 | $73,632 |
Source: SEC Form 4 filings · as of 2026-07-01